LA

Lokesh Arora

Active Director Director DIN 08076639
DIN 08076639 First appointment Feb 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value •••• Premium profile

About Lokesh Arora

Data last updated:

Lokesh Arora is a Director at Phycrus Remedies Private Limited (since 2018). The company operates in Trading. Phycrus Remedies Private Limited reported revenue of ₹23.6 Lakh (FY 2025).

DIN 08076639
Primary Designation Director
Industry Trading
First Appointment 28 Feb 2018
Oldest Company Age 8 yrs
Largest company Phycrus Remedies Private Limited · ₹23.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Phycrus Remedies Private Limited U51909MP2018PTC045152
Director28 Feb 20182018₹23.6 Lakh (FY 2025)Active

Board colleagues of Lokesh Arora

Directorship timeline

Open interactive timeline →
Phycrus Remedies Private Limited
Premium access

Shareholding and investment profile for Lokesh Arora

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lokesh Arora

Lokesh Arora currently holds 1 directorship: Phycrus Remedies Private Limited (Director, since 28 Feb 2018, revenue ₹23.6 Lakh (FY 2025)).

Lokesh Arora was first appointed on 28 Feb 2018 as Director at Phycrus Remedies Private Limited.

The current boards of Lokesh Arora's companies include Lakshya Arora (Phycrus Remedies Private Limited), Manas Arora (Phycrus Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available